Talks/Presentations

 

2019

190. TBD. Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR (2019/2020 TBD).

189. TBD. African Materials Research Society Meeting, Arusha, Tanzania (December 9-12, 2019).

188. TBD. Center for Nanoscale Materials, Argonne National Laboratory, Argonne, IL (September 18, 2019).

187. TBD. 37th Biennial Meeting of the Spanish Royal Society of Chemistry, San Sebastian, Spain, May 26-30, 2019.

186. TBD. Perimeter Institute for Theoretical Physics, Waterloo, Canada (May 1, 2019).

185. Aptamer-Field-Effect Transistor Microprobes for in Vivo Neurotransmitter Detection. Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, Philadelphia, PA (March 17-21, 2019).

2018

184. Functional biomaterials and biosensors. Expanding Frontiers in Chemical Sciences: American Chemical Society and Indian Academy of Science, Banaras Hindu University, Uttar Pradesh, India (November 1, 2018).

183. Functional biomaterials and biosensors. Indian Institute of Technology, New Dehli, India (October 30, 2018).

182. Functional biomaterials and biosensors. 14th International Conference on Atomically Controlled Surfaces, Interfaces and Nanostructures (ACSIN14), Sendai, Japan (October 24, 2018).

181. Electronic neurotransmitter sensing. Cell Press—NERF: Neurotechnologies, KU Leuven, Belgium (September 30-October 1, 2018).

180. Aptamer-field-effect transistor biosensors. International Conference on Nanotechnologies and Biosciences, Heraklion, Crete (September 24-28, 2018).

179. Field-effect transistor biosensors. Micro- and Nanotechnologies for Medicine: Emerging Frontiers and Applications, California NanoSystems Institute, University of California, Los Angeles, CA (July 20, 2018).

178. Serotonin transporter function and anxiety-related behavior. Genetic, Physiologic, and Therapeutic Perspectives on Transporters in the Nervous System, International Society for Neurochemistry Satellite Meeting, Maintenon, France (August 26, 2017).

178. International Society for Serotonin Research, Cork, Ireland (July 15-19, 2018).

177. Multiplexed serotonin and dopamine monitoring: Why faster is better v2.0. Monitoring Molecules in Neuroscience: 17th International Conference, Oxford, UK (March 25-29, 2018).

176. Neurotransmitter sensing via aptamer-field-effect transistors. Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, Orlando, FL (February 26-March 1, 2018).

175. Rapid pulse voltammetry for selective neurotransmitter sensing. Ralph N. Adams Symposium Award, Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, Orlando, FL (February 26-March 1, 2018).

174. Neurotransmitter sensing via aptamer-field-effect transistors. Atlantic Basin Conference on Chemistry, Cancun, Mexico (January 23-26, 2018).

2017

2016

2015

2014

2013

  • 117. Serotonin in depression & anxiety: From translational medicine to a chemical connectome. Department of Chemistry, University of Minnesota, Minneapolis, MN (October 29, 2013).
  • 116. SERT gene variants: A complex case for involvement in mood disorders and their treatment. Zilkha Neurogenetics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA (September 18, 2013).
  • 115. Serotonin in depression & anxiety: From translational medicine to a chemical connectome. Chemistry & Biology Interface Day, University of California, Los Angeles, CA (September 5, 2013).
  • 114. Serotonin in depression & anxiety: From translational medicine to a chemical connectome. Joint Research Institute, Beijing, China (July 1, 2013).
  • 113. Brain mapping. Three Pillars, One University, University of California, Los Angeles, CA (April 23, 2013)   
  • 112. Toward a chemical connectome. Leonardo Art Science Rendezvous, Speaking Your Mind, UCLA Art | Sci Center, Los Angeles, CA (April 18, 2013) 
  • 111. Brain biosensing: From micro to nano. Florida International University, Miami, FL (February 14, 2013)

2012

  • 110. Serotonin in depression & anxiety: From translational medicine to a chemical connectome. 2012 Smalley Institute /Rice Centennial Lecture Series, Rice University, Houston, TX (November 12, 2012).
  • 109. Serotonin in anxiety and mood: New insights based on biosensing. University of California, Los Angeles Semel Institute Psychiatry Grand Rounds, Los Angeles, CA (October 30, 2012).
  • 108. The neurochip: A functional nanomaterial for multiplexed biorecognition. California NanoSystems Institute/Taiwan National Program on Nanotechnology Joint Workshop, National Tsing Hua University, Hsinchu, Taiwan (October 3, 2012).
  • 107. Imaging neurotransmitter-functionalized nanomaterials: Toward nanobiosensing. Monitoring Molecules in Neuroscience, 14th International Conference, London, England (September 19, 2012).
  • 106. Monitoring serotonin: Why faster is better. Monitoring Molecules in Neuroscience, 14th International Conference, London, England (September 17, 2012).
  • 105. Serotonin in anxiety and depression: From genetics to nanobiosensing. Jilin University, Changchun, China (June 13, 2012).
  • 104. Serotonin in anxiety and depression: Genetics and predicting treatment response. Harbin Institute of Technology, Harbin, China (June 12, 2012).
  • 103. The neurochip: Functional nanomaterials for multiplexed biorecognition. 5th International Symposium on Bioanalysis, Biomedical Engineering and Nanotechnology (ISBBN 2012), Hunan University, Changsha, China (June 9, 2012).
  • 102. Brain biosensing: From micro to nano. Biomedical Engineering Program, University of California, Los Angeles, CA (May 17, 2012).
  • 101. Desperately seeking serotonin: Mood and anxiety disorders and their treatment. Center of Excellence for Neurosciences, Texas Tech University Health Sciences Center, El Paso, TX (April 23, 2012).
  • 100. Serotonin transporter function in peripheral blood cells as a predictor of SSRI responsiveness in the treatment of major depressive disorder. Wayne State University School of Medicine, Detroit, MI (April 4, 2012).
  • 99. Brain biosensing: From micro to nano. Department of Chemistry, Wayne State University, Detroit, MI (April 3, 2012).

2011

  • 98. In search of brain biosensors. Indiana University, Department of Chemistry, Bloomington, IL (October 25, 2011). 
  • 97. Multiplexed capture of biological targets. Panel session on Nanobiotechnology & Nanomedicine, ChinaNANO2011 Meeting, Beijing, China (September 7-9, 2011).
  • 96. Nanoengineered materials for biosensor design. Nanoelectronic Devices for Defense & Security Conference, New York University Polytechnic, Brooklyn NY (August 29-September 1, 2011).
  • 95. Brain biosensing: From micro to nano. Department of Bioengineering, University of Washington, Seattle, WA (May 9, 2011).
  • 94. Biomarkers for depression. School of Natural Sciences, University of California, Merced, CA (April 29, 2011).
  • 93. Brain biosensing: From micro to nano. Department of Chemistry, Ben-Gurion University of the Negev (January 19, 2011).
  • 92. Brain biosensing: From micro to nano. Department of Organic Chemistry, The Weizmann Institute (January 18, 2011).

2010

  • 91. Micro- to nanoscales for brain biosensing: Desperately seeking serotonin. School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, UK (September 17, 2010).
  • 90. Molecular and behavioral influences of the serotonin transporter and its gene variants: Focus on anxiety. Institute of Psychology, Chinese Academy of Sciences (August 24, 2010). 
  • 89. In search of brain nanobiosensors: Neurotransmitter nanoarchitectures and biomolecule recognition. Distinguished Lecture: Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences (August 23, 2010). 
  • 88.In search of brain nanobiosensors: Neurotransmitter nanoarchitectures and biomolecule recognition. IEEE NANO 2010 - Joint Symposium with NANO Korea 2010, Seoul, Korea (August 19, 2010).
  • 87. Effects of serotonin transporter deficiency on extracellular serotonin and other neurotransmitters following MDMA and serotonin-related toxicity models. XXVII Congress of the CINP (Collegium Internationale Neuropsychopharmacologicum), Hong Kong (June 9, 2010). 

2009

  • 86. Serotonin and the misbehaving brain. Department of Chemistry, University of Gothenburg, Gothenburg, Sweden (November 6, 2009).
  • 85. Moving from micro - to nanoscales for brain biosensing: Small molecule recognition as a critical first step. International Institute for Nanotechnology 2009 Symposium, Northwestern University, Evanston, IL (October 29, 2009).­ 
  • 84. Molecular ­and behavioral influences of the serotonin transporter and its gene variants, School of Biological Sciences, Fudan University, Shanghai, China (September 4, 2009). 
  • 83. Brain Probes: From micro to nano. Cross-Disciplinary Scholars in Science and Technology (CSST) Program, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA (August 10, 2009).­ 
  • 82. In search of brain nanobiosensors: Small molecule recognition and biomolecule capture as important first steps. Department of Chemistry, Universidad de Los Andes, Merida, Venezuela (May 22, 2009). 
  • 81. In search of brain nanobiosensors: Small molecule recognition and biomolecule capture as critical first steps. 237th ACS National Meeting & Exposition, Salt Lake City, UT (March 22, 2009). 
  • 80. Faster sampling & insights into adaptive responses in serotonin signaling. 60th Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, Chicago, IL (March 11, 2009).

2008

  • 79. In vivo approaches to investigating serotonin neurochemistry: From micro- to nanoscales. Chemistry Colloquium, Lycoming College, Lycoming, PA (October 17, 2008).
  • 78. Interpreting neurotransmitter release in light of altered baseline levels. 12th International Conference on In Vivo Methods, Vancouver, British Columbia, Canada (August 13, 2008).
  • 77. From genes to drugs: SERT-mediated regulation of BDNF, neurogenesis and anxiety. Serotonin Club Meeting, Oxford, England (July 17-19, 2008). 
  • 76. Genetic and environmental predispositions to anxiety: Serotonin transporter and stress. Brain Research Institute, University of California Los Angeles, CA (May 12, 2008).
  • 75. New agonies over Ecstasy: Serotonin and psychostimulants. 59th Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, New Orleans, LA (March 6, 2008). 
  • 74. In search of brain nanobiosensors: Small molecule recognition as an important first step. 59th Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, New Orleans, LA (March 6, 2008).
  • 73. Frightening complexity of the genetics of anxiety. Genetics Colloquium, Intercollege Program in Genetics, Pennsylvania State University, University Park, PA (February 15, 2008). 
  • 72. Serotonin neurochemistry and the origins of anxiety. Department of Chemistry, Vanderbilt University, Nashville, TN (February 4, 2008).

2007

  • 71. Serotonin transporter: A genetic predisposition to a lifetime of anxiety. Department of Chemistry, University of Pittsburgh, Pittsburgh, PA (November 26, 2007).
  • 70. Why I became a scientist! Expanding Your Horizons Conference for 6th-8th grade girls, Women in Science and Engineering Program, Pennsylvania State University, University Park, PA (November 19, 2007).
  • 69. Influence of serotonin transporter gene variants on uptake and anxiety. Department of Chemistry, Vanderbilt University, Nashville, TN (October 30, 2007). 
  • 68. Genetic predisposition to a lifetime of anxiety: The serotonin transporter and brain-derived neurotrophic factor. School of Behavioral and Brain Sciences, University of Texas at Dallas, Dallas, TX (October 8, 2007). 
  • 67. Serotonin neurochemistry and the misbehaving brain. Hanyang University, Seoul, South Korea, June 18, 2007. 
  • 66. In search of brain nanobiosensors: Small molecule recognition as an important first step. 2007 International Conference on Scanning Probe Microscopies, Cantilever-Based Sensors, Nanostructures, Biosensors and Biochips, Jeju Island, South Korea (June 14, 2007). 
  • 65. The neurochip: An advanced nanomaterial for the development of novel biosensors and functionally-directed proteomics. Engineering Conferences International Conference on Nanoscience & Nanotechnology for Biological/Biomedical/Chemical Sensing, Hong Kong (June 6, 2007). 
  • 64. Genetic predisposition to a lifetime of anxiety: The serotonin transporter and brain-derived neurotrophic factor. Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA (May 14, 2007). 
  • 63. The neurochip: An advanced nanomaterial for the development of novel biosensors and functionally directed proteomics. 58th Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, Chicago, IL (February 28, 2007). 
  • 62. Serotonin and the misbehaving brain: Unraveling the biology of anxiety and depression. Pennsylvania State University Lectures on the Frontiers of Science, University Park, PA (February 10, 2007). 
  • 61. Developing nanobiosensors for neurotransmitters: Assembly, patterning and application of optimally diluted biospecific capture surfaces. Mesilla Chemistry Workshop on Electron Transfer and Molecular Devices, Mesilla, NM (February 7, 2007).

2006

  • 60. The unusual effects of MDMA and methamphetamine in mice with reduced serotonin transporter expression. Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX (November 15, 2006).
  • 59. The serotonin system as a potential therapeutic target in the treatment of early Alzheimer's disease. Department of Pharmacology, Penn State College of Medicine, Hershey, PA (October 9, 2006). 
  • 58. The neurochip: An advanced nanomaterial for the development of novel biosensors and functionally-directed proteomics. Department of Chemistry, University of Wisconsin, Madison, WI (September 28, 2006). 
  • 57. Nanoscale study of heterogeneous brain architectures: Understanding disease mechanisms and devising novel therapeutics. 23rd National Meeting of the American Chemical Society Meeting, San Francisco, CA (September 10, 2006). 
  • 56. The neurochip: Nanostructured neurotransmitter derivatized surfaces for biosensor development. Department of Chemistry, University of California at Davis, Davis, CA (September 8, 2006).
  • 55. Serotonin and the aging brain. Department of Neuroscience, Bordeaux 2 University, Bordeaux, France (July 25, 2006). 
  • 54. MDMA-induced serotonin and dopamine release does not stimulate locomotor activity in SERT knockout mice: Importance of 5-HT1B receptors. Monitoring Molecules in Neuroscience, 11th International Conference on In Vivo Methods, Sardinia, Italy (May 21, 2006). 
  • 53. Serotonin uptake measured by chronoamperometry yields new insights into transporter function. National Institute of Mental Health, Bethesda, MD (February 22, 2006). 
  • 52. The neurochip: Nanostructured neurotransmitter derivatized surfaces for biosensor development. The Houston Society for Engineering in Medicine and Biology Annual Meeting, Houston, TX (February 10, 2006).

2005

  • 51. Serotonin and the misbehaving brain. Department of Biochemistry, Trinity College, Dublin, Ireland (December 9, 2005).
  • 50. Serotonin degeneration in Alzheimer’s disease. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA (May 24, 2005). 
  • 49. The neurochip: An advanced nanomaterial for the development of novel biosensors and functionally-directed proteomics. Foundations of Nanoscience Meeting, Snowbird, UT (April 25, 2005). 
  • 48. Neurotransmitter chip for biosensor design and functionally-directed proteomics. Department of Chemistry, Tokyo Metropolitan University, Tokyo, Japan (March 22, 2005). 
  • 47. Serotonin in the aging brain: Can SRI’s be used to delay neurodegeneration? 2005 Analytical Grantee Symposium, Analytical Partnerships: Transforming Concepts into Medicines, Eli Lilly & Company, Indianapolis, IN (February 22, 2005). 
  • 46. Monoamine uptake revisited using carbon fiber microelectrodes and chronoamperometry. 37th Annual Winter Conference on Brain Research, Breckenridge, CO (January 22, 2005). 

2004

  • 45. Serotonin and the misbehaving brain. Chemistry Department Colloquium, The Pennsylvania State University, University Park, PA (November 4, 2004).
  • 44. The neurochip: An advanced nanomaterial for the development of novel biosensors and functionally-directed proteomics. CrossOver 2004, Pennsylvania State University, University Park, PA (October 21, 2004). 
  • 43. Serotonin degeneration and Alzheimer’s disease. Department of Chemistry, Trinity University, San Antonio, TX (September 30, 2004). 
  • 42. Serotonin and the misbehaving brain. Department of Chemistry, Muhlenberg College, Allentown, PA (May 4, 2004). 
  • 41. Serotonin, reward and drugs of abuse. Department of Chemistry, University of Michigan, Ann Arbor, MI (February 19, 2004). 
  • 40. The effects of reduced serotonin transporter expression on neurotransmission, plasticity and behavior. National Center for Biological Sciences, TATA Institute, Bangalore, India (January 3, 2004). 

2003

  • 39. The relationship between serotonin and BDNF as trophic factors. 33rd Annual Meeting of the Society for Neuroscience, New Orleans, LA (November 11, 2003).
  • 38. Serotonin and the misbehaving brain: Using analytical chemistry to meet biologic challenges. Department of Chemistry, University of Illinois Urbana Champagne, Urbana, IL (October 24, 2003). 
  • 37. Novel tools for the dynamic analysis of brain chemistry. Midwest Union of Analytical Chemistry Committee Meeting, Indiana University Purdue University Indianapolis, Indianapolis, IN (October, 10, 2003). 
  • 36. SERT as a key regulator of brain-derived neurotrophic factor expression. Monitoring Molecules in Neuroscience: 10th International Conference on In Vivo Methods, Stockholm, Sweden (June 25, 2003). 
  • 35. SERT as a key regulator of serotonergic signaling and the effects on anxiety-related behavior. Monitoring Molecules in Neuroscience: 10th International Conference on In Vivo Methods, Stockholm, Sweden (June 25, 2003). 
  • 34. Serotonin and the fountain of youth: The chemistry of the aging brain. Department of Chemistry, Ohio State University, Columbus, OH (April 8, 2003). 
  • 33. Serotonin and the misbehaving brain. Department of Chemistry, St. Joseph’s University, Philadelphia, PA (April 2, 2003). 
  • 32. Electroanalytical methodology elucidates changes in serotonin and dopamine neurotransmission in genetically engineered mouse models of brain disease. 2003 Pittsburgh Conference, Orlando, FL (March 12, 2003). 
  • 31. Serotonin and the misbehaving brain. Department of Chemistry, Duke University, Raleigh-Durham, NC (February 7, 2003). 
  • 30. Serotonin and its reciprocal relationship with BDNF. 35th Annual Winter Conference on Brain Research, Salt Lake City, UT (January 26, 2003).

2002

  • 29. Electroanalytical methods elucidate modest but biologically relevant changes in serotonin and dopamine neurotransmission. Department of Chemistry, University of North Carolina, Chapel Hill, NC (November 11, 2002).
  • 28. Is α-synuclein giving us the run around? Department of Neurology, Columbia University Medical School, New York, NY (October 24, 2002). 
  • 27. Serotonin and the misbehaving brain. Department of Chemistry, University of Texas at Austin, Austin, TX (October 17, 2002). 
  • 26. Measurements in biological systems. Midwest Union of Analytical Chemistry Committee Meeting, University of Pittsburgh, Pittsburgh, PA (October, 3, 2002). 
  • 25. Serotonin and the misbehaving brain. Department of Chemistry, University of Pittsburgh, Pittsburgh, PA (September 19, 2002). 
  • 24. Serotonin and the misbehaving brain. Department of Chemistry, Emory University, Atlanta, GA (September 13, 2002). 
  • 23. Serotonin and the misbehaving brain. Department of Chemistry, Georgia Institute of Technology, Atlanta, GA (September 12, 2002). 
  • 22. The role of serotonin in MDMA-induced hyperactivity and neurotoxicity. Centers for Disease Control/National Institute for Occupational Safety and Health, Morgantown, WV (August 16, 2002). 
  • 21. Measuring serotonin in the study of anxiety. NSF-REU Program, Department of Chemistry, James Madison University, Harrisonburg, VA (June 27, 2002). 
  • 20. What do neuroscientists do? North Hills Junior High School, Pittsburgh, PA (May 3, 2002). 
  • 19. Deciphering the neurochemistry of anxiety. Department of Chemistry, Olivet Nazarene University, Chicago, IL (April 1, 2002). 
  • 18. What can measuring serotonin in vivo tell us about anxiety? 2002 Pittsburgh Conference, New Orleans, LA (March 20, 2002). 

2001

  • 17. Using electrochemical techniques to analyze serotonin neurochemistry. Federation of Analytical Chemistry & Spectroscopy Societies, Detroit, MI (October 10, 2001).
  • 16. Deciphering the neurochemistry of anxiety. Department of Chemistry, Juniata College, Juniata, PA (September 12, 2001). 
  • 15. Deciphering the neurochemistry of anxiety. College of Science Seminar Series, Grand Canyon University, Phoenix, AZ (March 23, 2001). 
  • 14. Deciphering the neurochemistry of anxiety. Department of Chemistry, Carlow College, Pittsburgh, PA (March 16, 2001). 
  • 13. Deciphering the neurochemistry of anxiety. Department of Chemistry, Western Kentucky University, Bowling Green, KY (March 2, 2001). 
  • 12. Deciphering the neurochemistry of anxiety. Department of Chemistry, Austin Peay University, Clarksville, TN (March 1, 2001). 
  • 11. Deciphering the neurochemistry of anxiety. Central Nervous System Preclinical Research Division, Astra Zeneca, Wilmington, DE (February 15, 2001). 

2000

  • 10. Deciphering the neurochemistry of anxiety. Division of Neuropathology, Johns Hopkins Medical Institutions, Baltimore, MD (December 12, 2000).
  • 9. The neurochemistry of anxiety. Department of Chemistry, Bloomsburg University, Bloomsburg, PA (November 17, 2000). 
  • 8. The neurochemistry of anxiety. Serotonin Club/Brain Research Bulletin Conference, New Orleans, LA (November 3, 2000). 
  • 7. Tools to probe brain chemistry. Pennsylvania State University, Department of Bioengineering, University Park, PA (September 28, 2000). 
  • 6. Criteria for evaluating neurotoxicity: Is 2'-NH2-MPTP a serotonergic neurotoxin? Pennsylvania State University Toxicology Forum, University Park, PA (May 10, 2000). 
  • 5. The heterogeneous nature of the brain: Impact on etiology, diagnosis and treatment of anxiety disorders. SurroMed, Inc., Palo Alto, CA (May 8, 2000). 
  • 4. Tools to study the brain serotonin system: Neurotoxicological approaches. St. Vincent’s College, Department of Chemistry, Latrobe, PA (March 24, 2000). 

1999

  • 3. Molecular mechanisms underlying adaptation of the presynaptic serotonin system in response to decreased SERT expression: Implications for understanding the etiology and treatment of depression and anxiety. Pennsylvania State University Neuroscience Day, Hershey Medical School, Hershey, PA (May 15, 1999).

1998

  • 2. Attempts to unravel differential neurochemistry in serotonin transporter knock-out mice. National Institute of Mental Health, Bethesda, MD (November 18, 1998).

1997

  • 1. 2'-NH2-MPTP selectively lesions serotonin and norepinephrine nerve terminals in three species by a mechanism of action involving oxygen free radicals. National Institute on Drug Abuse Director’s Seminar Series, Baltimore, MD (June 15, 1997).